Korea IND Filing Moves Alteogen's Eylea Biosimilar Forward
Executive Summary
South Korean biotech Alteogen is progressing the development of its Eylea biosimilar both at home and abroad, with the hope of becoming a global first mover with its version in wet AMD, backed by formulation and manufacturing patents.